Skip to main content
Top
Published in: Journal of Cancer Research and Clinical Oncology 12/2013

01-12-2013 | Original Paper

Prognostic nutritional index predicts outcomes of malignant pleural mesothelioma

Authors: Zhou-Hong Yao, Guang-Yan Tian, Yun-Yan Wan, Yan-Meng Kang, Hai-Sheng Guo, Qing-Hua Liu, Dian-Jie Lin

Published in: Journal of Cancer Research and Clinical Oncology | Issue 12/2013

Login to get access

Abstract

Purpose

Nutritional status has been associated with long-time outcomes in cancer patients. We investigated whether the prognostic nutritional index (PNI), an indicator of nutritional status, affects overall survival in patients with malignant pleural mesothelioma (MPM).

Methods

We enrolled 121 patients with histologically confirmed MPM, who had successfully undergone biopsy by medical thoracoscopy in this study. Demographic, clinical and laboratory data were collected retrospectively. The PNI was calculated as 10× serum albumin value (g/dl) + 0.005 × total lymphocyte count (per mm3) in peripheral blood. Univariate and multivariate analyses were used to identify prognostic factors.

Results

Mean pretreatment PNI was 44.6. PNI was significantly associated with age (P = 0.031), smoking habits (P = 0.039) and weight loss (P = 0.029). Survival analysis showed PNI to be an independent prognostic factor in MPM. Patients with lower PNIs (PNI < 44.6) had greater risk of death than those with higher PNIs (PNI ≥ 44.6; hazard ratio: 2.290; 95 % confidence interval: 1.415–3.706; P = 0.001). These analyses were adjusted for patient age, gender, smoking habits, dyspnea, chest pain, weight loss, primary site of tumor, histology, platinum-based systemic chemotherapy, hospital and stage.

Conclusions

Pretreatment PNI is a novel independent prognostic factor in MPM.
Literature
go back to reference Andreoli A, De Lorenzo A, Cadeddu F, Iacopino L, Grande M (2011) New trends in nutritional status assessment of cancer patients. Eur Rev Med Pharmacol Sci 15(5):469–480PubMed Andreoli A, De Lorenzo A, Cadeddu F, Iacopino L, Grande M (2011) New trends in nutritional status assessment of cancer patients. Eur Rev Med Pharmacol Sci 15(5):469–480PubMed
go back to reference Bagheri R, Haghi SZ, Rahim MB, Attaran D, Toosi MS (2011) Malignant pleural mesothelioma: clinicopathologic and survival characteristic in a consecutive series of 40 patients. Ann Thorac Cardiovasc Surg Off J Assoc Thorac Cardiovasc Surg Asia 17(2):130–136 Bagheri R, Haghi SZ, Rahim MB, Attaran D, Toosi MS (2011) Malignant pleural mesothelioma: clinicopathologic and survival characteristic in a consecutive series of 40 patients. Ann Thorac Cardiovasc Surg Off J Assoc Thorac Cardiovasc Surg Asia 17(2):130–136
go back to reference Baldwin C, Spiro A, McGough C, Norman AR, Gillbanks A, Thomas K, Cunningham D, O’Brien M, Andreyev HJ (2011) Simple nutritional intervention in patients with advanced cancers of the gastrointestinal tract, non-small cell lung cancers or mesothelioma and weight loss receiving chemotherapy: a randomised controlled trial. J Hum Nutr diet Off J British Diet Assoc 24(5):431–440. doi:10.1111/j.1365-277X.2011.01189.x CrossRef Baldwin C, Spiro A, McGough C, Norman AR, Gillbanks A, Thomas K, Cunningham D, O’Brien M, Andreyev HJ (2011) Simple nutritional intervention in patients with advanced cancers of the gastrointestinal tract, non-small cell lung cancers or mesothelioma and weight loss receiving chemotherapy: a randomised controlled trial. J Hum Nutr diet Off J British Diet Assoc 24(5):431–440. doi:10.​1111/​j.​1365-277X.​2011.​01189.​x CrossRef
go back to reference Borasio P, Berruti A, Bille A, Lausi P, Levra MG, Giardino R, Ardissone F (2008) Malignant pleural mesothelioma: clinicopathologic and survival characteristics in a consecutive series of 394 patients. Eur J Cardio-Thorac. Surg Off J Eur Assoc Cardio-Thorac Surg 33(2):307–313. doi:10.1016/j.ejcts.2007.09.044 CrossRef Borasio P, Berruti A, Bille A, Lausi P, Levra MG, Giardino R, Ardissone F (2008) Malignant pleural mesothelioma: clinicopathologic and survival characteristics in a consecutive series of 394 patients. Eur J Cardio-Thorac. Surg Off J Eur Assoc Cardio-Thorac Surg 33(2):307–313. doi:10.​1016/​j.​ejcts.​2007.​09.​044 CrossRef
go back to reference de Perrot M, Feld R, Cho BC, Bezjak A, Anraku M, Burkes R, Roberts H, Tsao MS, Leighl N, Keshavjee S, Johnston MR (2009) Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Clin Oncol Off J Am Soc Clin Oncol 27(9):1413–1418. doi:10.1200/JCO.2008.17.5604 CrossRef de Perrot M, Feld R, Cho BC, Bezjak A, Anraku M, Burkes R, Roberts H, Tsao MS, Leighl N, Keshavjee S, Johnston MR (2009) Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Clin Oncol Off J Am Soc Clin Oncol 27(9):1413–1418. doi:10.​1200/​JCO.​2008.​17.​5604 CrossRef
go back to reference Edwards JG, Abrams KR, Leverment JN, Spyt TJ, Waller DA, O’Byrne KJ (2000) Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systems. Thorax 55(9):731–735PubMedCentralCrossRefPubMed Edwards JG, Abrams KR, Leverment JN, Spyt TJ, Waller DA, O’Byrne KJ (2000) Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systems. Thorax 55(9):731–735PubMedCentralCrossRefPubMed
go back to reference Flores RM, Zakowski M, Venkatraman E, Krug L, Rosenzweig K, Dycoco J, Lee C, Yeoh C, Bains M, Rusch V (2007) Prognostic factors in the treatment of malignant pleural mesothelioma at a large tertiary referral center. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer 2(10):957–965. doi:10.1097/JTO.0b013e31815608d9 Flores RM, Zakowski M, Venkatraman E, Krug L, Rosenzweig K, Dycoco J, Lee C, Yeoh C, Bains M, Rusch V (2007) Prognostic factors in the treatment of malignant pleural mesothelioma at a large tertiary referral center. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer 2(10):957–965. doi:10.​1097/​JTO.​0b013e31815608d9​
go back to reference Fulkerson JA, French SA (2003) Cigarette smoking for weight loss or control among adolescents: gender and racial/ethnic differences. J Adolesc Health Off Publ Soc Adolesc Med 32(4):306–313CrossRef Fulkerson JA, French SA (2003) Cigarette smoking for weight loss or control among adolescents: gender and racial/ethnic differences. J Adolesc Health Off Publ Soc Adolesc Med 32(4):306–313CrossRef
go back to reference Herndon JE, Green MR, Chahinian AP, Corson JM, Suzuki Y, Vogelzang NJ (1998) Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B. Chest 113(3):723–731CrossRefPubMed Herndon JE, Green MR, Chahinian AP, Corson JM, Suzuki Y, Vogelzang NJ (1998) Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B. Chest 113(3):723–731CrossRefPubMed
go back to reference Kanda M, Fujii T, Kodera Y, Nagai S, Takeda S, Nakao A (2011) Nutritional predictors of postoperative outcome in pancreatic cancer. British J Surg 98(2):268–274. doi:10.1002/bjs.7305 CrossRef Kanda M, Fujii T, Kodera Y, Nagai S, Takeda S, Nakao A (2011) Nutritional predictors of postoperative outcome in pancreatic cancer. British J Surg 98(2):268–274. doi:10.​1002/​bjs.​7305 CrossRef
go back to reference Kao SC, Vardy J, Chatfield M, Corte P, Pavlakis N, Clarke C, van Zandwijk N, Clarke S (2013) Validation of prognostic factors in malignant pleural mesothelioma: a retrospective analysis of data from patients seeking compensation from the New South Wales Dust Diseases Board. Clin Lung Cancer 14(1):70–77. doi:10.1016/j.cllc.2012.03.011 CrossRefPubMed Kao SC, Vardy J, Chatfield M, Corte P, Pavlakis N, Clarke C, van Zandwijk N, Clarke S (2013) Validation of prognostic factors in malignant pleural mesothelioma: a retrospective analysis of data from patients seeking compensation from the New South Wales Dust Diseases Board. Clin Lung Cancer 14(1):70–77. doi:10.​1016/​j.​cllc.​2012.​03.​011 CrossRefPubMed
go back to reference Khalid U, Spiro A, Baldwin C, Sharma B, McGough C, Norman AR, Eisen T, O’Brien ME, Cunningham D, Andreyev HJ (2007) Symptoms and weight loss in patients with gastrointestinal and lung cancer at presentation. Support Care Cancer Off J Multinatl Assoc Support Care Cancer 15(1):39–46. doi:10.1007/s00520-006-0091-0 Khalid U, Spiro A, Baldwin C, Sharma B, McGough C, Norman AR, Eisen T, O’Brien ME, Cunningham D, Andreyev HJ (2007) Symptoms and weight loss in patients with gastrointestinal and lung cancer at presentation. Support Care Cancer Off J Multinatl Assoc Support Care Cancer 15(1):39–46. doi:10.​1007/​s00520-006-0091-0
go back to reference Migita K, Takayama T, Saeki K, Matsumoto S, Wakatsuki K, Enomoto K, Tanaka T, Ito M, Kurumatani N, Nakajima Y (2013) The prognostic nutritional index predicts long-term outcomes of gastric cancer patients independent of tumor stage. Ann Surg Oncol. doi:10.1245/s10434-013-2926-5 PubMed Migita K, Takayama T, Saeki K, Matsumoto S, Wakatsuki K, Enomoto K, Tanaka T, Ito M, Kurumatani N, Nakajima Y (2013) The prognostic nutritional index predicts long-term outcomes of gastric cancer patients independent of tumor stage. Ann Surg Oncol. doi:10.​1245/​s10434-013-2926-5 PubMed
go back to reference Nozoe T, Kimura Y, Ishida M, Saeki H, Korenaga D, Sugimachi K (2002) Correlation of pre-operative nutritional condition with post-operative complications in surgical treatment for oesophageal carcinoma. Eur J Surg Oncol J Eur Soc Surg Oncol British Assoc Surg Oncol 28(4):396–400 Nozoe T, Kimura Y, Ishida M, Saeki H, Korenaga D, Sugimachi K (2002) Correlation of pre-operative nutritional condition with post-operative complications in surgical treatment for oesophageal carcinoma. Eur J Surg Oncol J Eur Soc Surg Oncol British Assoc Surg Oncol 28(4):396–400
go back to reference Okada I, Shirahata A, Soda H, Saitou M, Kigawa G, Nemoto H, Sanada Y, Hibi K (2012) Significance of Onodera’s prognostic nutritional index for treating unresectable or recurrent colorectal cancer with chemotherapy. Gan to kagaku ryoho Cancer Chemother 39(2):231–235 Okada I, Shirahata A, Soda H, Saitou M, Kigawa G, Nemoto H, Sanada Y, Hibi K (2012) Significance of Onodera’s prognostic nutritional index for treating unresectable or recurrent colorectal cancer with chemotherapy. Gan to kagaku ryoho Cancer Chemother 39(2):231–235
go back to reference Onodera T, Goseki N, Kosaki G (1984) Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. Nihon Geka Gakkai zasshi 85(9):1001–1005PubMed Onodera T, Goseki N, Kosaki G (1984) Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. Nihon Geka Gakkai zasshi 85(9):1001–1005PubMed
go back to reference Proctor MJ, Morrison DS, Talwar D, Balmer SM, Fletcher CD, O’Reilly DS, Foulis AK, Horgan PG, McMillan DC (2011) A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow inflammation outcome study. Eur J Cancer 47(17):2633–2641. doi:10.1016/j.ejca.2011.03.028 CrossRefPubMed Proctor MJ, Morrison DS, Talwar D, Balmer SM, Fletcher CD, O’Reilly DS, Foulis AK, Horgan PG, McMillan DC (2011) A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow inflammation outcome study. Eur J Cancer 47(17):2633–2641. doi:10.​1016/​j.​ejca.​2011.​03.​028 CrossRefPubMed
go back to reference Ray-Coquard I, Cropet C, Van Glabbeke M, Sebban C, Le Cesne A, Judson I, Tredan O, Verweij J, Biron P, Labidi I, Guastalla JP, Bachelot T, Perol D, Chabaud S, Hogendoorn PC, Cassier P, Dufresne A, Blay JY (2009) Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas. Cancer Res 69(13):5383–5391. doi:10.1158/0008-5472.CAN-08-3845 PubMedCentralCrossRefPubMed Ray-Coquard I, Cropet C, Van Glabbeke M, Sebban C, Le Cesne A, Judson I, Tredan O, Verweij J, Biron P, Labidi I, Guastalla JP, Bachelot T, Perol D, Chabaud S, Hogendoorn PC, Cassier P, Dufresne A, Blay JY (2009) Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas. Cancer Res 69(13):5383–5391. doi:10.​1158/​0008-5472.​CAN-08-3845 PubMedCentralCrossRefPubMed
go back to reference Rusch VW (1995) A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group. Chest 108(4):1122–1128CrossRefPubMed Rusch VW (1995) A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group. Chest 108(4):1122–1128CrossRefPubMed
go back to reference Ryan M, White K, Roydhouse JK, Fethney J (2012) A description of the nutritional status and quality of life of Australian gynaecological cancer patients over time. Eur J Oncol Nurs Off J Eur Oncol Nurs Soc 16(5):453–459. doi:10.1016/j.ejon.2011.10.007 CrossRef Ryan M, White K, Roydhouse JK, Fethney J (2012) A description of the nutritional status and quality of life of Australian gynaecological cancer patients over time. Eur J Oncol Nurs Off J Eur Oncol Nurs Soc 16(5):453–459. doi:10.​1016/​j.​ejon.​2011.​10.​007 CrossRef
go back to reference Smale BF, Mullen JL, Buzby GP, Rosato EF (1981) The efficacy of nutritional assessment and support in cancer surgery. Cancer 47(10):2375–2381CrossRefPubMed Smale BF, Mullen JL, Buzby GP, Rosato EF (1981) The efficacy of nutritional assessment and support in cancer surgery. Cancer 47(10):2375–2381CrossRefPubMed
go back to reference Tanrikulu AC, Abakay A, Kaplan MA, Kucukoner M, Palanci Y, Evliyaoglu O, Sezgi C, Sen H, Carkanat AI, Kirbas G (2010) A clinical, radiographic and laboratory evaluation of prognostic factors in 363 patients with malignant pleural mesothelioma. Respir Int Rev Thorac Dis 80(6):480–487. doi:10.1159/000321370 Tanrikulu AC, Abakay A, Kaplan MA, Kucukoner M, Palanci Y, Evliyaoglu O, Sezgi C, Sen H, Carkanat AI, Kirbas G (2010) A clinical, radiographic and laboratory evaluation of prognostic factors in 363 patients with malignant pleural mesothelioma. Respir Int Rev Thorac Dis 80(6):480–487. doi:10.​1159/​000321370
go back to reference Tong H, Isenring E, Yates P (2009) The prevalence of nutrition impact symptoms and their relationship to quality of life and clinical outcomes in medical oncology patients. Support Care Cancer Off J Multinatl Assoc Support Care Cancer 17(1):83–90. doi:10.1007/s00520-008-0472-7 Tong H, Isenring E, Yates P (2009) The prevalence of nutrition impact symptoms and their relationship to quality of life and clinical outcomes in medical oncology patients. Support Care Cancer Off J Multinatl Assoc Support Care Cancer 17(1):83–90. doi:10.​1007/​s00520-008-0472-7
go back to reference Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC (eds) (2004) World Health Organization Classification of Tumours. Pathology & Genetics. Tumours of the Lung, Pleura, Thymus and Heart. IARC, Lyon Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC (eds) (2004) World Health Organization Classification of Tumours. Pathology & Genetics. Tumours of the Lung, Pleura, Thymus and Heart. IARC, Lyon
go back to reference van Meerbeeck JP, Gaafar R, Manegold C, Van Klaveren RJ, Van Marck EA, Vincent M, Legrand C, Bottomley A, Debruyne C, Giaccone G (2005) Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada. J Clin Oncol Off J Am Soc Clin Oncol 23(28):6881–6889. doi:10.1200/JCO.20005.14.589 CrossRef van Meerbeeck JP, Gaafar R, Manegold C, Van Klaveren RJ, Van Marck EA, Vincent M, Legrand C, Bottomley A, Debruyne C, Giaccone G (2005) Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada. J Clin Oncol Off J Am Soc Clin Oncol 23(28):6881–6889. doi:10.​1200/​JCO.​20005.​14.​589 CrossRef
go back to reference Vogelzang NJ, Rusthoven JJ, Symanowski J, Denham C, Kaukel E, Ruffie P, Gatzemeier U, Boyer M, Emri S, Manegold C, Niyikiza C, Paoletti P (2003) Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol Off J Am Soc Clin Oncol 21(14):2636–2644. doi:10.1200/JCO.2003.11.136 CrossRef Vogelzang NJ, Rusthoven JJ, Symanowski J, Denham C, Kaukel E, Ruffie P, Gatzemeier U, Boyer M, Emri S, Manegold C, Niyikiza C, Paoletti P (2003) Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol Off J Am Soc Clin Oncol 21(14):2636–2644. doi:10.​1200/​JCO.​2003.​11.​136 CrossRef
go back to reference Wager-Srdar SA, Levine AS, Morley JE, Hoidal JR, Niewoehner DE (1984) Effects of cigarette smoke and nicotine on feeding and energy. Physiol Behav 32(3):389–395CrossRefPubMed Wager-Srdar SA, Levine AS, Morley JE, Hoidal JR, Niewoehner DE (1984) Effects of cigarette smoke and nicotine on feeding and energy. Physiol Behav 32(3):389–395CrossRefPubMed
Metadata
Title
Prognostic nutritional index predicts outcomes of malignant pleural mesothelioma
Authors
Zhou-Hong Yao
Guang-Yan Tian
Yun-Yan Wan
Yan-Meng Kang
Hai-Sheng Guo
Qing-Hua Liu
Dian-Jie Lin
Publication date
01-12-2013
Publisher
Springer Berlin Heidelberg
Published in
Journal of Cancer Research and Clinical Oncology / Issue 12/2013
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-013-1523-0

Other articles of this Issue 12/2013

Journal of Cancer Research and Clinical Oncology 12/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.